These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9348185)

  • 1. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.
    Dobnig H; Turner RT
    Endocrinology; 1997 Nov; 138(11):4607-12. PubMed ID: 9348185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
    Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
    Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.
    Iida-Klein A; Lu SS; Kapadia R; Burkhart M; Moreno A; Dempster DW; Lindsay R
    J Endocrinol; 2005 Sep; 186(3):549-57. PubMed ID: 16135674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
    DeLuca PP; Dani BA
    AAPS PharmSci; 2001; 3(4):E27. PubMed ID: 12049490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
    Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
    J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone.
    Turner RT; Lotinun S; Hefferan TE; Morey-Holton E
    J Appl Physiol (1985); 2006 Sep; 101(3):881-6. PubMed ID: 16675609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.
    Sato M; Vahle J; Schmidt A; Westmore M; Smith S; Rowley E; Ma LY
    Endocrinology; 2002 Sep; 143(9):3230-42. PubMed ID: 12193534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
    Hock JM; Fonseca J; Gunness-Hey M; Kemp BE; Martin TJ
    Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34).
    Suzuki Y; Nagase Y; Iga K; Kawase M; Oka M; Yanai S; Matsumoto Y; Nakagawa S; Fukuda T; Adachi H; Higo N; Ogawa Y
    J Pharm Sci; 2002 Feb; 91(2):350-61. PubMed ID: 11835195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
    Nozaka K; Miyakoshi N; Kasukawa Y; Maekawa S; Noguchi H; Shimada Y
    Bone; 2008 Jan; 42(1):90-7. PubMed ID: 17997377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry.
    Kitazawa R; Imai Y; Fukase M; Fujita T
    Bone Miner; 1991 Mar; 12(3):157-66. PubMed ID: 2021707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
    Hock JM; Hummert JR; Boyce R; Fonseca J; Raisz LG
    J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.